| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 109.35B | 110.39B | 105.20B | 106.17B | 95.71B | 65.83B |
| Gross Profit | 60.58B | 62.14B | 57.27B | 54.17B | 45.19B | 28.36B |
| EBITDA | 45.15B | 47.00B | 36.80B | 36.60B | 29.82B | 14.23B |
| Net Income | 26.61B | 27.74B | 21.38B | 20.68B | 16.67B | 5.33B |
Balance Sheet | ||||||
| Total Assets | 154.99B | 151.82B | 140.37B | 128.17B | 130.52B | 96.51B |
| Cash, Cash Equivalents and Short-Term Investments | 25.84B | 34.98B | 35.33B | 29.29B | 29.36B | 20.53B |
| Total Debt | 19.62B | 21.08B | 23.20B | 19.93B | 19.56B | 15.58B |
| Total Liabilities | 59.48B | 55.90B | 55.25B | 54.39B | 65.94B | 43.20B |
| Stockholders Equity | 95.51B | 95.92B | 85.12B | 72.90B | 63.74B | 53.30B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 26.36B | 17.92B | 10.63B | 21.06B | 10.80B |
| Operating Cash Flow | 0.00 | 40.43B | 28.40B | 21.34B | 25.80B | 13.19B |
| Investing Cash Flow | 0.00 | -22.32B | -11.27B | -9.45B | -12.43B | -2.47B |
| Financing Cash Flow | 0.00 | -21.29B | -10.73B | -12.54B | -5.78B | -4.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥693.42B | 15.50 | 8.07% | 2.85% | 11.18% | -0.75% | |
74 Outperform | ¥7.69T | 59.16 | 8.95% | 1.88% | 2.88% | 28.76% | |
74 Outperform | ¥594.07B | 16.10 | 6.30% | 2.16% | 1.90% | -105.45% | |
71 Outperform | ¥1.12T | 20.85 | 15.75% | 1.08% | 19.45% | 41.03% | |
70 Outperform | ¥398.45B | 14.11 | ― | 2.18% | -6.10% | -7.03% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
60 Neutral | ¥29.05B | 19.00 | 3.48% | 2.38% | 3.53% | 10.37% |